<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高季刊</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac&amp;ff=202307 19162154&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-<description>心血管高季刊：PubMed 的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.17.9.post6+86293ac&amp;ff=20230719162154&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS 源 (2.17.9.post6+86293ac)</generator><language> zh</language><lastbuilddate> 2023 年 7 月 19 日星期三 20:21:56 +0000</lastbuilddate><pubDate> Wed, 19 Jul 2023 06:00:00 -0400</pubDate><ttl> 120</ttl><item><title>利用天然 T1 作图追踪心脏轻链淀粉样变性的治疗反应</title><link/>https://pubmed.ncbi.nlm.nih.gov/37466990/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论和相关性：治疗反应中天然 T1 的变化反映了 T2 和 ECV 变化的综合结果，与传统心脏反应标志物的变化以及死亡率相关。然而，作为一项单中心研究，这些结果需要在更大的队列中进行外部验证。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> JAMA Cardiol。2023 年 7 月 19 日。doi：10.1001/jamacardio.2023.2010。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">重要性：心脏磁共振 (CMR) 成像衍生的细胞外体积 (ECV) 测绘由造影前和造影后 T1 生成，可准确确定心脏轻链淀粉样变性的治疗反应。无需造影即可导出的原生 T1 测绘已证明诊断和预测的准确性，但尚不清楚连续原生 T1 测量是否也可以跟踪心脏治疗反应。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：评估原生 T1 映射是否可以测量心脏治疗反应以及原生 T1 变化与预后之间的关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">设计、背景和参与者：这项单中心队列研究评估了诊断为心脏轻链淀粉样变性的患者（2016 年 1 月至 2020 年 12 月），这些患者在诊断时接受了 CMR 扫描，并在化疗后接受了重复扫描。分析于 2016 年 1 月至 2022 年 10 月之间进行。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">主要结果和措施：比较自然 T1 降低、稳定或增加的患者之间的生物标志物和心脏成像参数，以及自然 T1 变化与死亡率之间的关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：该研究包括 221 名患者（平均 [SD] 年龄，64.7 [10.6] 岁；130 名男性 [59%]）。6 个月时，183 名患者（平均 [SD] 年龄，64.8 [10.5] 岁；110 名男性 [60%]）接受了重复 CMR 成像。8 名患者 (4%) 发生了 50 毫秒或更长的自然 T1 减少，所有患者均患有良好的血液学反应；相比之下，42 名患者 (23%) 出现自然 T1 增加 50 毫秒或更长，其中大多数血液学反应较差 (27 [68%])。12 个月时，160 名患者（平均 [SD] 年龄，63.8 [11.1] 岁；94 名男性 [59%]）进行了重复 CMR 扫描。%），所有患者都有良好的血液学反应，并且与N 端脑钠肽前体减少（中位数 [IQR]，2638 [913-5767] vs 423 [128-1777] ng/L；P &lt; .001），最大壁厚度（平均值 [SD]，14.8 [3.6] vs 13.6 [3.9] mm；P = .009）和 E/e&#39;（平均值 [SD]，14）减少.9 [6.8] 对比 12.0 [4.0]；P = .007），纵向应变改善（平均值 [SD]，-14.8% [4.0%] 对比 -16.7% [4.0%]；P = .004），心肌 T2（平均值 [SD]，52.3 [2.9] 对比 P &lt; .001）和 ECV（平均值 [SD]，0.47 [0.07]）降低] vs 0.42 [0.08]；P &lt; .001)。12 个月时，24 名患者 (15%) 出现天然 T1 增加，其中大多数患者血液学反应较差 (17 [71%])，并且与 N 端脑前钠利尿肽增加相关（中位数 [IQR]，1622 [554-5487] vs 3150 [1161-874] 5] ng/L；P = .007），左心室射血分数降低（平均 [SD]，65.8% [11.4%] vs 61.5% [12.4%]；P = .009），心肌 T2（平均 [SD]，52.5 [2.7] vs 55.3 [4.2] 毫秒；P &lt; .001）和 ECV（平均 [SD]）增加，0.48 [0.09] vs 0.56 [0.09]；P &lt; .001）。6 个月时心肌天然 T1 的变化与死亡率独立相关（风险比，2.41 [95% CI，1.36-4. 27]；P = .003）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论和相关性：治疗反应中天然 T1 的变化反映了 T2 和 ECV 变化的综合结果，与传统心脏反应标志物的变化以及死亡率相关。然而，作为一项单中心研究，这些结果需要在更大的队列中进行外部验证。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37466990/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37466990</a> | DOI： <a href=https://doi.org/10.1001/jamacardio.2023.2010>10.1001/jamacardio.2023.2010</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37466990</guid><pubDate> Wed, 19 Jul 2023 06:00:00 -0400</pubDate><dc:creator>亚当·约安努</dc:creator><dc:creator>里希·K·帕特尔</dc:creator><dc:creator>安娜·马丁内斯-纳哈罗</dc:creator><dc:creator>优素福·拉兹维</dc:creator><dc:creator>阿尔多斯特法诺·波卡里</dc:creator><dc:creator>穆罕默德·U·拉乌夫 (Muhammad U Rauf)</dc:creator><dc:creator>鲁斯·博尔休斯</dc:creator><dc:creator>雅各布·费尔南多-塞耶斯</dc:creator><dc:creator>鲁塔·维辛斯凯特</dc:creator><dc:creator>弗朗西斯科·班德拉</dc:creator><dc:creator>图沙尔·科特查</dc:creator><dc:creator>露西娅·文内里</dc:creator><dc:creator>丹尼尔·奈特</dc:creator><dc:creator>夏洛特·马尼斯蒂</dc:creator><dc:creator>詹姆斯·穆恩</dc:creator><dc:creator>海伦·拉赫曼</dc:creator><dc:creator>卡罗尔·惠兰</dc:creator><dc:creator>彼得·凯尔曼</dc:creator><dc:creator>菲利普·N·霍金斯</dc:creator><dc:creator>朱利安·D·吉尔莫尔</dc:creator><dc:creator>阿舒托什·韦查莱卡</dc:creator><dc:creator>玛丽安娜丰塔纳</dc:creator><dc:date>2023-07-19</dc:date><dc:source>美国医学会杂志心脏病学</dc:source><dc:title>利用天然 T1 作图追踪心脏轻链淀粉样变性的治疗反应</dc:title><dc:identifier>下午：37466990</dc:identifier><dc:identifier> doi:10.1001/jamacardio.2023.2010</dc:identifier></item><item><title>轻链心脏淀粉样变性治疗中的成像生物标志物</title><link/>https://pubmed.ncbi.nlm.nih.gov/37466953/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>没有摘要</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> JAMA Cardiol。2023 年 7 月 19 日。doi：10.1001/jamacardio.2023.2030。印刷前在线。</p><p><b>无摘要</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37466953/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37466953</a> | DOI： <a href=https://doi.org/10.1001/jamacardio.2023.2030>10.1001/jamacardio.2023.2030</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37466953</guid><pubDate> Wed, 19 Jul 2023 06:00:00 -0400</pubDate><dc:creator>萨拉·AM·卡迪</dc:creator><dc:date>2023-07-19</dc:date><dc:source>美国医学会杂志心脏病学</dc:source><dc:title>轻链心脏淀粉样变性治疗中的成像生物标志物</dc:title><dc:identifier>下午：37466953</dc:identifier><dc:identifier> doi:10.1001/jamacardio.2023.2030</dc:identifier></item><item><title>与脑死亡相关的左心室功能障碍：供体心脏研究的结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/37465972/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论：与脑死亡相关的左心室功能障碍发生在许多潜在的心脏捐赠者身上，有时是可逆的。这些发现可以为捐赠者评估期间做出的决策提供信息，并有助于指导捐赠者心脏接受移植。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 19 日。doi：10.1161/CIRCULATIONAHA.122.063400。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：符合脑死亡标准的潜在捐赠者的左心室功能障碍通常会导致不使用捐赠心脏进行移植，但对其发生率或病理生理学知之甚少。解决这些未知问题是 DHS（捐赠心脏研究）的主要目标，这是一项多中心前瞻性队列研究。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：2015 年 2 月至 2020 年 5 月期间，国土安全部在美国 8 个器官获取组织通过神经学确定死亡情况招募了潜在捐赠者 (n=4333)。数据包括施用的药物、系列诊断测试和经胸超声心动图 (TTE)：(1) 正式诊断脑死亡后 48 小时内；(2) 如果最初存在左心室 (LV) 功能障碍，则为 24±6 小时后。左心室 (LV) 功能障碍被定义为左室射血分数 &lt;50%，如果第二次 TTE 上左室射血分数 >;50%，则认为是可逆的。还检查了 TTE 是否存在左室局部室壁运动异常及其可逆性。我们评估了左室功能障碍、供体心脏接受移植和受者 1 年生存率之间的关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：4333 名潜在捐献者中，有 3794 名通过神经学死亡判定解释了初始 TTE。这些 TTE 中总共 493 名 (13%) 显示出左室功能障碍。在进行初始 TTE 的捐献者中，左室功能障碍与年龄较小、体重不足以及较高的 NT-proBNP（N 端 B 型利尿钠肽前体）和肌钙蛋白水平有关。初始 LV 的捐献者子集 (n=224)功能障碍；在这个子集中，130 (58%) 表现出可逆性。左心室功能正常的供体心脏中有 60% 被接受移植，而有可逆性左心室功能障碍的心脏为 56%，有不可逆性左心室功能障碍的心脏为 24%。供体左心室功能障碍，无论是否可逆，与受体 1 年生存率无关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：与脑死亡相关的左心室功能障碍发生在许多潜在的心脏捐赠者身上，有时是可逆的。这些发现可以为捐赠者评估期间做出的决策提供信息，并有助于指导捐赠者心脏接受移植。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37465972/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37465972</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.063400>10.1161 / CIRCULATIONAHA.122.063400</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37465972</guid><pubDate> Wed, 19 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Kiran K Khush更多</dc:creator><dc:creator>达伦·马利诺斯基</dc:creator><dc:creator>海伦·路易卡特</dc:creator><dc:creator>布赖恩·韦达</dc:creator><dc:creator>塔尼·格罗特</dc:creator><dc:creator>约翰·阮</dc:creator><dc:creator>约翰贝尔彻</dc:creator><dc:creator>哈维尔·涅托</dc:creator><dc:creator>尼科尔·奈德林格</dc:creator><dc:creator>艾哈迈德·萨利希更多</dc:creator><dc:creator>PJ Geraghty更多</dc:creator><dc:creator>布鲁斯·尼斯利更多</dc:creator><dc:creator>马丁·詹德里萨克</dc:creator><dc:creator>托马斯·皮尔逊</dc:creator><dc:creator>R-帕特里克·伍德</dc:creator><dc:creator>张士奇</dc:creator><dc:creator>翁英杰</dc:creator><dc:creator>乔纳森·扎罗夫</dc:creator><dc:date>2023-07-19</dc:date><dc:source>循环</dc:source><dc:title>与脑死亡相关的左心室功能障碍：供体心脏研究的结果</dc:title><dc:identifier>下午：37465972</dc:identifier><dc:identifier> doi:10.1161/循环AHA.122.063400</dc:identifier></item><item><title>经皮冠状动脉介入治疗期间的血管内成像：美国的时间趋势和临床结果</title><link/>https://pubmed.ncbi.nlm.nih.gov/37464975/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论：在接受 PCI 的医疗保险受益人中，IVI 的使用在过去十年中有所增加，但仍然相对较少。IVI 指导的 PCI 与较低的风险调整死亡率、急性心肌梗死、重复 PCI 和 MACE 相关。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2023 Jul 19:ehad430.doi: 10.1093/eurheartj/ehad430. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：先前的试验表明，与标准血管造影指导相比，血管内成像（IVI）引导的经皮冠状动脉介入治疗（PCI）导致靶病变血运重建和主要不良心血管事件（MACE）的频率降低。IVI引导的PCI在美国当代临床实践中的采用和相关结果仍不清楚。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法和结果：对 2013 年 1 月 1 日至 2019 年 12 月 31 日的医疗保险受益人数据进行回顾性队列研究，以评估住院患者和门诊患者中 IVI 指导 PCI 与单独血管造影指导 PCI 相比的时间趋势和结果比较。结果为 MI 或 1 年时重复 PCI。多变量 Cox 回归用于估计 IVI 指导与结果之间的调整后关联。伪造终点（住院肺炎和住院治疗）髋部骨折）用于评估潜在的不可测量的混杂因素。操作员 IVI 使用情况各不相同，操作员 IVI 使用中位数为 3.92%（四分位数范围 0.36%-12.82%）。PCI 期间使用 IVI 与较低的调整后 1 年死亡率相关[调整后风险比 (aHR) 0.96, 95% 置信区间 (CI) 0.94-0.98]、MI (aHR 0.97, 95) % CI 0.95-0.99)、重复 PCI (aHR 0.74, 95% CI 0.73-0.75) 和 MACE (aHR 0.85, 95% CI 0.84-0.86).04) 或髋部骨折 (aHR 1.02, 95% CI 0.94-1.10)。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：在接受 PCI 的医疗保险受益人中，IVI 的使用在过去十年中有所增加，但仍然相对较少。IVI 指导的 PCI 与较低的风险调整死亡率、急性心肌梗死、重复 PCI 和 MACE 相关。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37464975/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37464975</a> | DOI： <a href=https://doi.org/10.1093/eurheartj/ehad430>10.1093/eurheartj/ehad430</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37464975</guid><pubDate> Wed, 19 Jul 2023 06:00:00 -0400</pubDate><dc:creator>雷扎·法泽尔</dc:creator><dc:creator>——罗伯特·W·叶</dc:creator><dc:creator>——大卫·J·科恩</dc:creator><dc:creator>苏尼尔·V·拉奥</dc:creator><dc:creator>李思玲</dc:creator><dc:creator>杨松</dc:creator><dc:creator>埃里克·塞塞姆斯基</dc:creator><dc:date>2023-07-19</dc:date><dc:source>欧洲心脏杂志</dc:source><dc:title>经皮冠状动脉介入治疗期间的血管内成像：美国的时间趋势和临床结果</dc:title><dc:identifier>下午：37464975</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehad430</dc:identifier></item><item><title>使用人工智能对冠状动脉中易损动脉粥样硬化斑块进行成像的路线图</title><link/>https://pubmed.ncbi.nlm.nih.gov/37464183/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>人工智能 (AI) 可能会彻底改变医学图像的分析方式，并有可能改善冠状动脉中易损或高风险动脉粥样硬化斑块的识别和分析，从而推动冠状动脉疾病的治疗取得进展。由于心脏和呼吸运动以及心血管结构的小尺寸，分析具有挑战性。此外，冠状动脉成像数据的分析... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。2023 年 7 月 18 日。doi：10.1038/s41569-023-00900-3。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">人工智能 (AI) 可能会彻底改变医学图像的分析方式，并有可能改善冠状动脉中易损或高风险动脉粥样硬化斑块的识别和分析，从而推动冠状动脉疾病的治疗取得进展。由于心脏和呼吸运动以及心血管结构的小尺寸，读卡器间和读卡器内的变异性，分析具有挑战性。人工智能有潜力改善对冠状动脉中易损斑块图像的评估，但需要稳健的开发、测试和验证。将人类专业知识与人工智能相结合可能有助于对使用 CT、MRI、PET、血管内超声检查和光学相干断层扫描获得的图像进行可靠和有效的解释。在本路线图中，我们回顾了人工智能应用于易损斑块成像的现有证据我们还概述了人工智能技术的未来要求，以解决偏见、不确定性、可解释性和普遍性，这些对于人工智能及其临床应用的接受都至关重要处理预计不断增长的冠状动脉成像程序量。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37464183/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37464183</a> | DOI： <a href=https://doi.org/10.1038/s41569-023-00900-3>10.1038/s41569-023-00900-3</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37464183</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>伯恩哈德·福尔默</dc:creator><dc:creator>——米歇尔·C·威廉姆斯</dc:creator><dc:creator>达米尼·戴伊</dc:creator><dc:creator>阿明·阿尔巴-扎德</dc:creator><dc:creator>帕尔·毛罗维奇-霍瓦特</dc:creator><dc:creator>里克·H·J·A·沃勒伯格</dc:creator><dc:creator>丹尼尔·吕克特</dc:creator><dc:creator>朱莉娅·施纳贝尔</dc:creator><dc:creator>——大卫·E·纽比</dc:creator><dc:creator>——马克·R·德韦克</dc:creator><dc:creator>朱利奥·瓜廖米</dc:creator><dc:creator>福尔克马尔·法尔克</dc:creator><dc:creator>阿尔多·J·巴斯克斯·梅斯基塔</dc:creator><dc:creator>费德里科·比亚瓦蒂</dc:creator><dc:creator>伊万娜·伊斯古姆</dc:creator><dc:creator>——马克·杜威</dc:creator><dc:date>2023-07-18</dc:date><dc:source> 《自然》评论、心脏病学</dc:source><dc:title>使用人工智能对冠状动脉中易损动脉粥样硬化斑块进行成像的路线图</dc:title><dc:identifier>下午：37464183</dc:identifier><dc:identifier> doi:10.1038/s41569-023-00900-3</dc:identifier></item><item><title>肌节突变携带者和明显肥厚型心肌病的微观结构和微血管表型</title><link/>https://pubmed.ncbi.nlm.nih.gov/37463608/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论：显微结构改变和 MVD 发生在明显的 HCM 中，并且在 G+ 和 G- 患者中有所不同。两者也发生在肌节突变携带者无肥大的情况下，其变化与心电图异常相关。心肌微结构和微血管功能的可测量变化是疾病修饰治疗新兴时代的早期表型生物标志物。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>。2023 年 7 月 18 日。doi：10.1161/CIRCULATIONAHA.123.063835。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：在肥厚型心肌病 (HCM) 中，心肌细胞紊乱和微血管疾病 (MVD) 与不良事件有关，最近的证据表明这些不良事件可能发生较早。为了评估它们作为早期和疾病特异性生物标志物的效用，我们测量了3 个 HCM 组中的心肌微观结构和 MVD - 显性、基因型阳性 (G+LVH+) 或基因型阴性 (G-LVH+) 以及亚临床 (G +LVH-) HCM - 探索与电变化和遗传底物的关系。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：这是一项多中心合作研究 206 名受试者：101 名明显 HCM 患者（51 G+LVH+ 和 50 G-LVH+）、77 名 G+LVH- 患者和 28 名匹配的健康志愿者。所有受试者均接受了 12 导联心电图检查，定量灌注心脏磁共振成像（测量心肌血流量、心肌灌注储备和灌注缺陷），以及测量分数各向异性（预期值越低，越混乱）的心脏扩散张量成像、平均扩散率（反映心肌细胞堆积/间质扩张）和第二特征向量角（测量小张方向）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：与健康志愿者相比，明显 HCM 患者的微观结构发生了改变（各向异性分数较低，平均扩散率较高，第二特征向量角较高；所有<i>P</i> &lt;0.001）和 MVD（应激性心肌血流量和心肌灌注储备较低；均G-LVH+患者与G+LVH+患者相似，但第二特征向量角升高（调整左心室肥厚和纤维化后<i>P</i> &lt;0.001）。在明显<i>疾病</i>中，所有G+患者均发现灌注缺陷，但并非所有G-患者均发现灌注缺陷。 （100% [51/51] 对比 82% [41/50]； <i>P</i> = 0.001）。与健康志愿者相比，G+LVH- 患者的微观结构也发生了类似的改变，尽管程度较小（所有扩散<i>P</i> &lt;0.001），和 MVD（应激性心肌血流减少 [ <i>P</i> = 0.015]，28% 的健康志愿者发生灌注缺陷 [ <i>P</i> = 0.002]）。在调整纤维化后，紊乱和 MVD 与明显疾病和亚临床疾病的病理心电图异常独立相关和左心室肥厚（显性：分数各向异性：异常心电图优势比，3.3， <i>P</i> = 0.01；应激性心肌血流：优势比，2.8， <i>P</i> = 0.015；亚临床：分数各向异性优势比，4.0， <i>P</i> = 0.001；心肌灌注储备优势比，2.2， <i>P</i> =0.049）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：显微结构改变和 MVD 发生在明显的 HCM 中，并且在 G+ 和 G- 患者中有所不同。两者也发生在肌节突变携带者无肥大的情况下，其变化与心电图异常相关。心肌微结构和微血管功能的可测量变化是疾病修饰治疗新兴时代的早期表型生物标志物。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37463608/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37463608</a> | DOI： <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063835>10.1161 / CIRCULATIONAHA.123.063835</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37463608</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>乔治·乔伊更多</dc:creator><dc:creator>克里斯托弗·凯利</dc:creator><dc:creator>马修·韦伯</dc:creator><dc:creator>伊恩·皮尔斯</dc:creator><dc:creator>欧文·泰</dc:creator><dc:creator>路易丝·麦克格拉斯</dc:creator><dc:creator>保拉·贝拉斯克斯</dc:creator><dc:creator>丽贝卡·K·休斯</dc:creator><dc:creator>华夫林·科特瓦尔</dc:creator><dc:creator>阿尔卡·达斯</dc:creator><dc:creator>陈菲奥娜</dc:creator><dc:creator>阿塔纳西奥斯·巴卡拉科斯</dc:creator><dc:creator>马西米利亚诺·洛伦齐尼</dc:creator><dc:creator>康斯坦丁诺斯·萨瓦蒂斯</dc:creator><dc:creator>Sam A Mohiddin更多</dc:creator><dc:creator>——彼得·W·麦克法兰</dc:creator><dc:creator>米歇尔·奥里尼</dc:creator><dc:creator>夏洛特·马尼斯蒂</dc:creator><dc:creator>彼得·凯尔曼</dc:creator><dc:creator>罗德里·H·戴维斯</dc:creator><dc:creator>Pier D Lambiase更多</dc:creator><dc:creator>克里斯托弗·阮</dc:creator><dc:creator>于尔根·E·施奈德</dc:creator><dc:creator>梅特·托梅</dc:creator><dc:creator>加布里埃拉·卡普尔</dc:creator><dc:creator>艾丽卡·达尔梅利纳</dc:creator><dc:creator>詹姆斯·C·穆恩</dc:creator><dc:creator>路易斯·R·洛佩斯</dc:creator><dc:date>2023-07-18</dc:date><dc:source>循环</dc:source><dc:title>肌节突变携带者和明显肥厚型心肌病的微观结构和微血管表型</dc:title><dc:identifier>下午：37463608</dc:identifier><dc:identifier> doi:10.1161/循环AHA.123.063835</dc:identifier></item><item><title>缺血试验中完全血运重建的影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/37462593/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论：如果实现 CR（尤其是 ACR），INV 策略的结果可能会得到改善（国际医学和侵入性方法比较健康有效性研究 [ISCHEMIA]；NCT01471522）。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> J Am Coll Cardiol. 2023 Jul 11​​:S0735-1097(23)06031-X. doi: 10.1016/j.jacc.2023.06.015. 印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：在一些先前的研究中，解剖性完全血运重建（ACR）和功能性完全血运重建（FCR）与死亡和心肌梗死（MI）的减少有关。与接受侵入性（INV）患者相比，完全血运重建（CR）的影响保守（CON）管理策略尚未见报道。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：在 ISCHEMIA（医疗和侵入性方法的健康有效性比较国际研究）试验中，在未接受冠状动脉旁路移植术的慢性冠心病患者中随机接受 INV 与 CON 治疗的患者中，我们检查了以下内容：1）ACR 和2) 与 CON 治疗相比，所有 INV 患者实现 CR 的潜在影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在独立的核心实验室评估INV组的ACR和FCR，检查INV患者CR的多变量调整结果，然后进行逆概率加权模型来估计所有INV患者获得CR后的治疗效果。与 CON 管理。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：1,824 名 INV 患者中，43.4% 和 58.4% 实现了 ACR 和 FCR。与不完全血运重建相比，ACR 与 4 年心血管死亡率或 MI 发生率降低相关。通过逆概率加权模型，对所有 2,296 名 INV 患者的 ACR 进行了比较2,498 名 CON 患者的研究与较低的 4 年心血管死亡或 MI 发生率相关（差异 -3.5；95% CI：-7.2% 至 0.0%）。相比之下，INV 减去心血管死亡或 MI 的事件发生率差异整个 ISCHEMIA 试验中的 CON 为 -2.4%。结果与 FCR 相似，但不太明显。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：如果实现 CR（尤其是 ACR），INV 策略的结果可能会得到改善（国际医学和侵入性方法比较健康有效性研究 [ISCHEMIA]；NCT01471522）。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37462593/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37462593</a> | DOI： <a href=https://doi.org/10.1016/j.jacc.2023.06.015>10.1016/j.jacc.2023.06.015</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37462593</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>格雷格·W·斯通</dc:creator><dc:creator>齐亚德·阿​​里</dc:creator><dc:creator>肖恩·M·奥布莱恩</dc:creator><dc:creator>——格蕾丝·罗兹</dc:creator><dc:creator>菲利普·杰内勒</dc:creator><dc:creator>斯里帕尔·班加罗尔</dc:creator><dc:creator>克雷顿·马夫罗马蒂斯</dc:creator><dc:creator>詹妮弗·霍斯特</dc:creator><dc:creator>奥维迪乌·德雷斯勒</dc:creator><dc:creator>鲍建强</dc:creator><dc:creator>兰吉特·纳斯</dc:creator><dc:creator>纳加拉惹穆迪</dc:creator><dc:creator>亚当·维特科斯基</dc:creator><dc:creator>苏丹舒·德维迪</dc:creator><dc:creator>奥尔加·博克里亚</dc:creator><dc:creator>陈吉彦</dc:creator><dc:creator>保拉·EP·斯马尼奥</dc:creator><dc:creator>迈克尔·H·皮卡德</dc:creator><dc:creator>伯纳德·R·柴特曼</dc:creator><dc:creator>——丹尼尔·S·伯曼</dc:creator><dc:creator>莱斯利·J·肖</dc:creator><dc:creator>威廉·博登</dc:creator><dc:creator>哈维·D·怀特</dc:creator><dc:creator>斯蒂芬·E·弗雷姆斯</dc:creator><dc:creator>伊夫·罗森伯格</dc:creator><dc:creator>哈莫尼·R·雷诺兹</dc:creator><dc:creator>约翰·斯珀图斯</dc:creator><dc:creator>——朱迪思·S·霍克曼</dc:creator><dc:creator>——大卫·J·马龙</dc:creator><dc:creator>缺血研究组</dc:creator><dc:date>2023-07-18</dc:date><dc:source>美国心脏病学会杂志</dc:source><dc:title>缺血试验中完全血运重建的影响</dc:title><dc:identifier>下午：37462593</dc:identifier><dc:identifier> doi:10.1016/j.jacc.2023.06.015</dc:identifier></item><item><title>棕色脂肪组织和 BMP3b 减少心脏缺血再灌注损伤</title><link/>https://pubmed.ncbi.nlm.nih.gov/37462036/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论：本研究的结果表明，BAT 和 BMP3b（一种由 BAT 分泌的蛋白质）在 I/R 损伤模型中具有心脏保护作用。增加 BMP3b 水平或靶向 Smad 1/5 的干预措施可能代表减少心肌损伤的新治疗方法在 I/R 损伤中。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 18 日。doi：10.1161/CIRCRESAHA.122.322337。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：尽管治疗取得了进展，心肌梗死 (MI) 仍是全世界心力衰竭和死亡的主要原因，缺血和再灌注 (I/R) 都会导致心脏损伤。之前使用非再灌注 MI 小鼠模型进行的一项研究表明，心肌梗死 (MI) 激活棕色脂肪组织 (BAT)。最近的研究表明，BAT 分泌的分子靶向心脏。我们研究了 BAT 是否可以减轻 I/R 中的心脏损伤，并试图鉴定 BAT 分泌的潜在心脏保护蛋白。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在野生型 (WT) 小鼠和 BAT 功能受损的小鼠（解偶联蛋白 1 [ <i>Ucp1</i> ] 缺陷小鼠）中进行有或没有 BAT 移植的心肌 I/R 手术。为了鉴定 BAT 产生的潜在心脏保护因子， RNA <i>-</i> seq 在 WT 和<i>Ucp1</i> <sup><i>-</i></sup> <sup><i>/-</i></sup>小鼠的 BAT 中进行。R 使用 BMP3b 进行处理。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：小鼠 BAT 功能障碍与 I/R 后 MI 增大有关；相反，通过移植增加 BAT 会减小 MI 大小。我们确定 Bmp3b 是 I/R 后 BAT 分泌的蛋白质。与 WT 小鼠相比， <i>Bmp3b</i>缺陷的小鼠通过将 WT 小鼠的 BAT 移植到<i>Bmp3b</i>缺陷型小鼠中，增加功能性 BAT 可减少 I/R 损伤，而从<i>Bmp3b</i>缺陷型小鼠中移植 BAT 则不会。再灌注前用 BMP3b 处理 WT 小鼠可降低 MI 大小。BMP3b 的 MI 大小是通过 SMAD1/5 介导的/8. 在人类中，MI后血浆BMP3b水平升高，且与心脏损伤程度呈正相关。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：本研究的结果表明，BAT 和 BMP3b（一种由 BAT 分泌的蛋白质）在 I/R 损伤模型中具有心脏保护作用。增加 BMP3b 水平或靶向 Smad 1/5 的干预措施可能代表减少心肌损伤的新治疗方法在 I/R 损伤中。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37462036/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37462036</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.122.322337>10.1161/CIRCRESAHA.122.322337</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37462036</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>英格丽德·马蒂·帕米斯</dc:creator><dc:creator>罗布雷希特·图南</dc:creator><dc:creator>迈克尔·莫利</dc:creator><dc:creator>劳伦·格雷夫斯</dc:creator><dc:creator>赫苏斯·塔梅兹</dc:creator><dc:creator>亚历克斯·卡普兰</dc:creator><dc:creator>肯德拉·麦克戴德</dc:creator><dc:creator>姚文森</dc:creator><dc:creator>艾莉森·欣德尔</dc:creator><dc:creator>罗伯特·E·格斯坦</dc:creator><dc:creator>劳里·法雷尔</dc:creator><dc:creator>李莉</dc:creator><dc:creator>曾玉华</dc:creator><dc:creator>格森·普罗菲塔</dc:creator><dc:creator>伊曼纽尔·S·购买</dc:creator><dc:creator>唐纳德·B·布洛赫</dc:creator><dc:creator>玛丽埃尔·谢勒-克罗斯比</dc:creator><dc:date>2023-07-18</dc:date><dc:source>流通研究</dc:source><dc:title>棕色脂肪组织和 BMP3b 减少心脏缺血再灌注损伤</dc:title><dc:identifier>下午：37462036</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.122.322337</dc:identifier></item><item><title>乳糜微粒调节乳汁渗透性和肠道脂质吸收</title><link/>https://pubmed.ncbi.nlm.nih.gov/37462027/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>结论：我们的结果表明，ROCK 依赖性细胞骨架收缩的拮抗输入调节肠道和其他组织中淋巴连接的相互转换，提供了控制淋巴屏障的可调机制。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Circ Res. 2023 年 7 月 18 日。doi：10.1161/CIRCRESAHA.123.322607。印刷前在线。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：淋巴管负责组织引流，其功能障碍与慢性疾病有关。众所周知，淋巴管的摄取是通过毛细淋巴管内皮细胞 (LEC) 之间专门的开放细胞-细胞连接进行的，而收集 LEC 时的闭合连接可防止淋巴液渗漏。在发育和疾病中动态重塑，但淋巴通透性是如何调节的仍然知之甚少。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们使用各种基因工程小鼠模型，结合细胞、生化和分子生物学方法来阐明调节毛细淋巴管连接形态和功能的信号通路。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：通过研究肠乳毛细血管对称为乳糜微粒的脂蛋白颗粒的通透性，我们表明 ROCK（Rho 相关激酶）依赖性细胞骨架收缩性是 LEC 通透性调节的基本机制。锚定应力纤维。LEC 特异性 ROCK 缺失消除了连接开放和血浆脂质摄取。乳糜微粒还抑制 VEGF（血管内皮生长因子）-A 信号传导。通过 VEGFR（VEGF 受体）2 和 VEGFR3 依赖性 PI3K/AKT 激活小GTPase RAC1，从而限制 RhoA/ROCK 介导的细胞骨架收缩。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的结果表明，ROCK 依赖性细胞骨架收缩的拮抗输入调节肠道和其他组织中淋巴连接的相互转换，提供了控制淋巴屏障的可调机制。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/37462027/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37462027</a> | DOI： <a href=https://doi.org/10.1161/CIRCRESAHA.123.322607>10.1161/CIRCRESAHA.123.322607</a></p></div> ]]>;</content:encoded><guid ispermalink="false">发布：37462027</guid><pubDate> Tue, 18 Jul 2023 06:00:00 -0400</pubDate><dc:creator>乔治亚·扎卡达</dc:creator><dc:creator>陈迅</dc:creator><dc:creator>周学桐</dc:creator><dc:creator>马丁·兰格</dc:creator><dc:creator>曾雷</dc:creator><dc:creator>文宇Lv.</dc:creator><dc:creator>张旋</dc:creator><dc:creator>李云华</dc:creator><dc:creator>周伟斌</dc:creator><dc:creator>刘克利</dc:creator><dc:creator>陈东英</dc:creator><dc:creator>尼古拉斯·里卡德</dc:creator><dc:creator>廖詹姆斯</dc:creator><dc:creator>金英范</dc:creator><dc:creator>鲁伊·贝内迪托</dc:creator><dc:creator>莉娜·克莱森-威尔士</dc:creator><dc:creator>卡里·阿利塔洛</dc:creator><dc:creator>迈克尔·西蒙斯</dc:creator><dc:creator>容菊</dc:creator><dc:creator>李旭日</dc:creator><dc:creator>安妮·艾希曼</dc:creator><dc:creator>张峰</dc:creator><dc:date>2023-07-18</dc:date><dc:source>流通研究</dc:source><dc:title>乳糜微粒调节乳汁渗透性和肠道脂质吸收</dc:title><dc:identifier>下午：37462027</dc:identifier><dc:identifier> doi:10.1161/CIRCRESAHA.123.322607</dc:identifier></item><item><title>脊髓损伤个体心血管风险的诊断和管理：叙述性回顾</title><link/>https://pubmed.ncbi.nlm.nih.gov/37459417/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff = 20230719162154&amp;v=2.17.9.post6+86293ac<description>每年有超过 16 000 名美国人经历脊髓损伤 (SCI)，导致慢性残疾和其他继发后遗症。急性医疗管理的改进提高了预期寿命。心血管疾病是该人群的主要原因，并且似乎与一般人群相比，SCI 患者发生得更早。SCI 患者承受着传统心血管疾病危险因素的沉重负担，包括血脂异常和糖尿病等。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>流通</b>. 2023 年 7 月 18 日；148(3):268-277. doi: 10.1161/CIRCULATIONAHA.123.064859. Epub 2023 年 7 月 17 日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> More than 16 000 Americans experience spinal cord injury (SCI), resulting in chronic disability and other secondary sequelae, each year. Improvements in acute medical management have increased life expectancy. Cardiovascular disease is a leading cause of death in this population, and seems to occur earlier in individuals with SCI compared with the general population. People with SCI experience a high burden of traditional cardiovascular disease risk factors, including dyslipidemia and diabetes, and demonstrate anatomic, metabolic, and physiologic changes alongside stark reductions in physical activity after injury. They also experience multiple, complex barriers to care relating to disability and, in many cases, compounding effects of intersecting racial and socioeconomic health inequities. Given this combination of risk factors, some investigators have proposed that people with SCI are at increased risk for cardiovascular disease, beyond that associated with traditional risk factors, and SCI could be considered a risk-enhancing factor, analogous to other risk-enhancing factors defined by the 2019 American Heart Association/American College of Cardiology Primary Prevention Guidelines. However, more research is needed in this population to clarify the role of traditional risk factors, novel risk factors, health care access, social determinants of health, and intersectionality of disability, race, and socioeconomic status. There is an urgent need for primary care physicians and cardiologists to have awareness of the importance of timely diagnosis and management of cardiac risk factors for people with SCI.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459417/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459417</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064859>10.1161/CIRCULATIONAHA.123.064859</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459417</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Tara Lagu</dc:creator><dc:creator> Samantha L Schroth</dc:creator><dc:creator> Carol Haywood</dc:creator><dc:creator> Allen Heinemann</dc:creator><dc:creator> Allison Kessler</dc:creator><dc:creator> Leslie Morse</dc:creator><dc:creator> Sadiya S Khan</dc:creator><dc:creator> Kiarri N Kershaw</dc:creator><dc:creator> Mark S Nash</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Diagnosis and Management of Cardiovascular Risk in Individuals With Spinal Cord Injury: A Narrative Review</dc:title><dc:identifier> pmid:37459417</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064859</dc:identifier></item><item><title> Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459416/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):253-255. doi: 10.1161/CIRCULATIONAHA.123.065723. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459416/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459416</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065723>10.1161/CIRCULATIONAHA.123.065723</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459416</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Sana M Al-Khatib</dc:creator><dc:creator> Kevin L Thomas</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients</dc:title><dc:identifier> pmid:37459416</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.065723</dc:identifier></item><item><title> Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459415/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: Race- or ethnicity-based disparities persist in STEMI process metrics in both women and men, and mortality differences are observed in Hispanic White compared with non-Hispanic White women. Further research is essential to evolve systems of care to mitigate racial differences in STEMI outcomes. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):229-240. doi: 10.1161/CIRCULATIONAHA.123.065512. Epub 2023 Jul 17.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Systems of care have been developed across the United States to standardize care processes and improve outcomes in patients with ST-segment-elevation myocardial infarction (STEMI). The effect of contemporary STEMI systems of care on racial and ethnic disparities in achievement of time-to-treatment goals and mortality in STEMI is uncertain. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We analyzed 178 062 patients with STEMI (52 293 women and 125 769 men) enrolled in the American Heart Association Get With The Guidelines-Coronary Artery Disease registry between January 1, 2015, and December 31, 2021. Patients were stratified into and outcomes compared among 3 racial and ethnic groups: non-Hispanic White, Hispanic White, and Black. The primary outcomes were the proportions of patients achieving the following STEMI process metrics: prehospital ECG obtained by emergency medical services; hospital arrival to ECG obtained within 10 minutes for patients not transported by emergency medical services; arrival-to-percutaneous coronary intervention time within 90 minutes; and first medical contact-to-device time within 90 minutes. A secondary outcome was in-hospital mortality. Analyses were performed separately in women and men, and all outcomes were adjusted for age, comorbidities, acuity of presentation, insurance status, and socioeconomic status measured by social vulnerability index based on patients&#39; county of residence. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Compared with non-Hispanic White patients with STEMI, Hispanic White patients and Black patients had lower odds of receiving a prehospital ECG and achieving targets for door-to-ECG, door-to-device, and first medical contact-to-device times. These racial disparities in treatment goals were observed in both women and men, and persisted in most cases after multivariable adjustment. Compared with non-Hispanic White women, Hispanic White women had higher adjusted in-hospital mortality (odds ratio, 1.39 [95% CI, 1.12-1.72]), whereas Black women did not (odds ratio, 0.88 [95% CI, 0.74-1.03]). Compared with non-Hispanic White men, adjusted in-hospital mortality was similar in Hispanic White men (odds ratio, 0.99 [95% CI, 0.82-1.18]) and Black men (odds ratio, 0.96 [95% CI, 0.85-1.09]). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Race- or ethnicity-based disparities persist in STEMI process metrics in both women and men, and mortality differences are observed in Hispanic White compared with non-Hispanic White women. Further research is essential to evolve systems of care to mitigate racial differences in STEMI outcomes.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459415/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459415</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065512>10.1161/CIRCULATIONAHA.123.065512</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459415</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Asishana Osho</dc:creator><dc:creator> Marcelo F Fernandes</dc:creator><dc:creator> Ram Poudel</dc:creator><dc:creator> James de Lemos</dc:creator><dc:creator> Haoyun Hong</dc:creator><dc:creator> Juan Zhao</dc:creator><dc:creator> Shen Li</dc:creator><dc:creator> Kathie Thomas</dc:creator><dc:creator> Daniel S Kikuchi</dc:creator><dc:creator> Jessica Zegre-Hemsey</dc:creator><dc:creator> Nasrien Ibrahim</dc:creator><dc:creator> Nilay S Shah</dc:creator><dc:creator> Lori Hollowell</dc:creator><dc:creator> Jacqueline Tamis-Holland</dc:creator><dc:creator> Christopher B Granger</dc:creator><dc:creator> Mauricio Cohen</dc:creator><dc:creator> Timothy Henry</dc:creator><dc:creator> Alice K Jacobs</dc:creator><dc:creator> James G Jollis</dc:creator><dc:creator> Clyde W Yancy</dc:creator><dc:creator> Abhinav Goyal</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Race-Based Differences in ST-Segment-Elevation Myocardial Infarction Process Metrics and Mortality From 2015 Through 2021: An Analysis of 178 062 Patients From the American Heart Association Get With The Guidelines-Coronary Artery Disease Registry</dc:title><dc:identifier> pmid:37459415</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.065512</dc:identifier></item><item><title> Complex Adaptive Systems Simulation Modeling to Address Cardiovascular Disparities: Complex Science for a Complex Problem</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459414/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):201-203. doi: 10.1161/CIRCULATIONAHA.122.061728. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459414/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459414</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.122.061728>10.1161/CIRCULATIONAHA.122.061728</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459414</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Kamal H Henderson</dc:creator><dc:creator> Ross A Hammond</dc:creator><dc:creator> Jack B Homer</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Complex Adaptive Systems Simulation Modeling to Address Cardiovascular Disparities: Complex Science for a Complex Problem</dc:title><dc:identifier> pmid:37459414</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.122.061728</dc:identifier></item><item><title> Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459413/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: Among patients with NICM with an ICD for primary prevention, Black patients compared with White patients had a high risk and burden of VTA, ATA, and ICD therapies with a lower survival rate. Nevertheless, the overall benefit of the ICD was maintained and was similar to that of White patients. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):241-252. doi: 10.1161/CIRCULATIONAHA.123.065367. Epub 2023 Jul 17.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Black Americans have a higher risk of nonischemic cardiomyopathy (NICM) than White Americans. We aimed to evaluate differences in the risk of tachyarrhythmias among patients with an implantable cardioverter-defibrillator (ICD). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: The study population comprised 3895 ICD recipients in the United States enrolled in primary prevention ICD trials. Outcome measures included ventricular tachyarrhythmia (VTA), atrial tachyarrhythmia (ATA), ICD therapies, VTA burden (using Andersen-Gill recurrent event analysis), death, and the predicted benefit of the ICD. All events were adjudicated blindly. Outcomes were compared between self-reported Black patients versus White patients with cardiomyopathy (ischemic and NICM). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Black patients were more likely to be female (35% versus 22%) and younger (57±12 versus 62±12 years) with a higher frequency of comorbidities. In NICM, Black patients had a higher rate of first VTA, fast VTA, ATA, and appropriate and inappropriate ICD therapy (VTA ≥170 bpm, 32% versus 20%; VTA ≥200 bpm, 22% versus 14%; ATA, 25% versus 12%; appropriate therapy, 30% versus 20%; and inappropriate therapy, 25% versus 11%; <i>P</i> &lt;0.001 for all). Multivariable analysis showed that Black patients with NICM experienced a higher risk of all types of arrhythmia or ICD therapy (VTA ≥170 bpm, hazard ratio [HR] 1.71; VTA ≥200 bpm, HR 1.58; ATA, HR 1.87; appropriate therapy, HR 1.62; inappropriate therapy, HR 1.86; <i>P</i> ≤0.01 for all), higher burden of tachyarrhythmias or therapies (VTA, HR 1.84; appropriate therapy, HR 1.84; <i>P</i> &lt;0.001 for both), and a higher risk of death (HR 1.92; <i>P</i> =0.014). In contrast, in ischemic cardiomyopathy, the risk of all types of tachyarrhythmia, ICD therapy, or death was similar between Black patients and White patients. Both Black patients and White patients derived a significant and similar benefit from ICD implantation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Among patients with NICM with an ICD for primary prevention, Black patients compared with White patients had a high risk and burden of VTA, ATA, and ICD therapies with a lower survival rate. Nevertheless, the overall benefit of the ICD was maintained and was similar to that of White patients.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459413/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459413</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065367>10.1161/CIRCULATIONAHA.123.065367</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459413</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Arwa Younis</dc:creator><dc:creator> Sanah Ali</dc:creator><dc:creator> Eileen Hsich</dc:creator><dc:creator> Ido Goldenberg</dc:creator><dc:creator> Scott McNitt</dc:creator><dc:creator> Bronislava Polonsky</dc:creator><dc:creator> Mehmet K Aktas</dc:creator><dc:creator> Valentina Kutyifa</dc:creator><dc:creator> Oussama M Wazni</dc:creator><dc:creator> Wojciech Zareba</dc:creator><dc:creator> Ilan Goldenberg</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator</dc:title><dc:identifier> pmid:37459413</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.065367</dc:identifier></item><item><title> Strategies to Cultivate Diversity and Achieve Equity in Cardiovascular Clinical Trials</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459412/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):204-206. doi: 10.1161/CIRCULATIONAHA.123.065476. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459412/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459412</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065476>10.1161/CIRCULATIONAHA.123.065476</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459412</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Debra D Dixon</dc:creator><dc:creator> Consuelo H Wilkins</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Strategies to Cultivate Diversity and Achieve Equity in Cardiovascular Clinical Trials</dc:title><dc:identifier> pmid:37459412</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.065476</dc:identifier></item><item><title> Advancing Cardiovascular Health Equity in the United States: Now That We Know, Where Do We Go Next?</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459411/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):197-198. doi: 10.1161/CIRCULATIONAHA.123.065971. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459411/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459411</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065971>10.1161/CIRCULATIONAHA.123.065971</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459411</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Rishi K Wadhera</dc:creator><dc:creator> Karol E Watson</dc:creator><dc:creator> Mercedes R Carnethon</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Advancing Cardiovascular Health Equity in the United States: Now That We Know, Where Do We Go Next?</dc:title><dc:identifier> pmid:37459411</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.065971</dc:identifier></item><item><title> American Heart Association Program Aims to Boost Hispanic or Latino Clinician Representation in Cardiology</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459410/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):278-279. doi: 10.1161/CIRCULATIONAHA.123.064251. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459410/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459410</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064251>10.1161/CIRCULATIONAHA.123.064251</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459410</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Bridget M Kuehn</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> American Heart Association Program Aims to Boost Hispanic or Latino Clinician Representation in Cardiology</dc:title><dc:identifier> pmid:37459410</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064251</dc:identifier></item><item><title> Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459409/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: Historical redlining is associated with an increased risk of HF among Black patients. Contemporary zip code-level social determinants of health modify the relationship between redlining and HF risk, with the strongest relationship between redlining and HF observed in the most socioeconomically disadvantaged communities. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):210-219. doi: 10.1161/CIRCULATIONAHA.123.064351. Epub 2023 Jul 17.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: The association of historical redlining policies, a marker of structural racism, with contemporary heart failure (HF) risk among White and Black individuals is not well established. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We aimed to evaluate the association of redlining with the risk of HF among White and Black Medicare beneficiaries. Zip code-level redlining was determined by the proportion of historically redlined areas using the Mapping Inequality Project within each zip code. The association between higher zip code redlining proportion (quartile 4 versus quartiles 1-3) and HF risk were assessed separately among White and Black Medicare beneficiaries using generalized linear mixed models adjusted for potential confounders, including measures of the zip code-level Social Deprivation Index. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: A total of 2 388 955 Medicare beneficiaries (Black n=801 452; White n=1 587 503; mean age, 71 years; men, 44.6%) were included. Among Black beneficiaries, living in zip codes with higher redlining proportion (quartile 4 versus quartiles 1-3) was associated with increased risk of HF after adjusting for age, sex, and comorbidities (risk ratio, 1.08 [95% CI, 1.04-1.12]; <i>P</i> &lt;0.001). This association remained significant after further adjustment for area-level Social Deprivation Index (risk ratio, 1.04 [95% CI, 1.002-1.08]; <i>P</i> =0.04). A significant interaction was observed between redlining proportion and Social Deprivation Index ( <i>P</i> <sub>interaction</sub> &lt;0.01) such that higher redlining proportion was significantly associated with HF risk only among socioeconomically distressed regions (above the median Social Deprivation Index). Among White beneficiaries, redlining was associated with a lower risk of HF after adjustment for age, sex, and comorbidities (risk ratio, 0.94 [95% CI, 0.89-0.99]; <i>P</i> =0.02). </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Historical redlining is associated with an increased risk of HF among Black patients. Contemporary zip code-level social determinants of health modify the relationship between redlining and HF risk, with the strongest relationship between redlining and HF observed in the most socioeconomically disadvantaged communities.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459409/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459409</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064351>10.1161/CIRCULATIONAHA.123.064351</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459409</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Amgad Mentias</dc:creator><dc:creator> Mahasin S Mujahid</dc:creator><dc:creator> Andrew Sumarsono</dc:creator><dc:creator> Robert K Nelson</dc:creator><dc:creator> Justin M Madron</dc:creator><dc:creator> Tiffany M Powell-Wiley</dc:creator><dc:creator> Utibe R Essien</dc:creator><dc:creator> Neil Keshvani</dc:creator><dc:creator> Saket Girotra</dc:creator><dc:creator> Alanna A Morris</dc:creator><dc:creator> Mario Sims</dc:creator><dc:creator> Quinn Capers</dc:creator><dc:creator> Clyde Yancy</dc:creator><dc:creator> Milind Y Desai</dc:creator><dc:creator> Venu Menon</dc:creator><dc:creator> Shreya Rao</dc:creator><dc:creator> Ambarish Pandey</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries</dc:title><dc:identifier> pmid:37459409</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064351</dc:identifier></item><item><title> Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459408/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> CONCLUSIONS: Nonparticipation in cardiac rehabilitation, a cardiometabolic risk profile, and persistent smoking mediate income-dependent prognosis after MI. In the absence of randomized trials, this causal inference approach may guide decisions to improve health equity. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):256-267. doi: 10.1161/CIRCULATIONAHA.123.064440. Epub 2023 Jul 17.</p><p> <b>ABSTRACT</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> BACKGROUND: Low socioeconomic status is associated with worse secondary prevention use and prognosis after myocardial infarction (MI). Actions for health equity improvements warrant identification of risk mediators. Therefore, we assessed mediators of the association between socioeconomic status and first recurrent atherosclerotic cardiovascular disease event (rASCVD) after MI. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: In this cohort study on 1-year survivors of first-ever MI with Swedish universal health coverage ages 18 to 76 years, individual-level data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) and linked national registries was collected from 2006 through 2020. Exposure was socioeconomic status by disposable income quintile (principal proxy), educational level, and marital status. The primary outcome was rASCVD and secondary outcomes were cardiovascular and all-cause mortality. We initially assessed the incremental attenuation of hazard ratios with 95% CIs in sequential multivariable models adding groups of potential mediators (ie, previous risk factors, acute presentation and infarct severity, initial therapies, and secondary prevention). Thereafter, the proportion of excess rASCVD associated with a low income mediated through nonparticipation in cardiac rehabilitation, suboptimal statin management, a cardiometabolic risk profile, persistent smoking, and blood pressure above target after MI were calculated using causal mediation analysis. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Among 68 775 participants (73.8% men), 7064 rASCVD occurred during a mean 5.7-year follow-up. Income, adjusted for age, sex, and calendar year, was associated with rASCVD (hazard ratio, 1.63 [95% CI, 1.51-1.76] in the lowest versus highest income quintile). Risk attenuated most by adjustment for previous risk factors and by adding secondary prevention variables for a final model (hazard ratio, 1.38 [95% CI, 1.26-1.51]) in the lowest versus highest income quintile. The proportions of the excess 15-year rASCVD risk in the lowest income quintile mediated through nonparticipation in cardiac rehabilitation, cardiometabolic risk profile, persistent smoking, and poor blood pressure control were 3.3% (95% CI 2.1-4.8), 3.9% (95% CI, 2.9-5.5), 15.2% (95% 9.1-25.7), and 1.0% (95% CI 0.6-1.5), respectively. Risk mediation through optimal statin management was negligible. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSIONS: Nonparticipation in cardiac rehabilitation, a cardiometabolic risk profile, and persistent smoking mediate income-dependent prognosis after MI. In the absence of randomized trials, this causal inference approach may guide decisions to improve health equity.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459408/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459408</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC10348618/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">PMC10348618</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064440>10.1161/CIRCULATIONAHA.123.064440</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459408</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Joel Ohm</dc:creator><dc:creator> Ralf Kuja-Halkola</dc:creator><dc:creator> Anna Warnqvist</dc:creator><dc:creator> Henrike Häbel</dc:creator><dc:creator> Per H Skoglund</dc:creator><dc:creator> Johan Sundström</dc:creator><dc:creator> Kristina Hambraeus</dc:creator><dc:creator> Tomas Jernberg</dc:creator><dc:creator> Per Svensson</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction</dc:title><dc:identifier> pmid:37459408</dc:identifier><dc:identifier> pmc:PMC10348618</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064440</dc:identifier></item><item><title> Associations Between Maternal Sociodemographics and Hospital Mortality in Newborns With Prenatally Diagnosed Hypoplastic Left Heart Syndrome</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459407/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):283-285. doi: 10.1161/CIRCULATIONAHA.123.064476. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459407/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459407</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064476>10.1161/CIRCULATIONAHA.123.064476</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459407</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Keila N Lopez</dc:creator><dc:creator> Shaine A Morris</dc:creator><dc:creator> Anita Krishnan</dc:creator><dc:creator> Marni B Jacobs</dc:creator><dc:creator> Aarti H Bhat</dc:creator><dc:creator> Anjali Chelliah</dc:creator><dc:creator> Joanne S Chiu</dc:creator><dc:creator> Bettina F Cuneo</dc:creator><dc:creator> Grace Freire</dc:creator><dc:creator> Lisa K Hornberger</dc:creator><dc:creator> Lisa Howley</dc:creator><dc:creator> Nazia Husain</dc:creator><dc:creator> Catherine Ikemba</dc:creator><dc:creator> Ann Kavanaugh-McHugh</dc:creator><dc:creator> Shelby Kutty</dc:creator><dc:creator> Caroline Lee</dc:creator><dc:creator> Angela McBrien</dc:creator><dc:creator> Erik C Michelfelder</dc:creator><dc:creator> Nelangi M Pinto</dc:creator><dc:creator> Rachel Schwartz</dc:creator><dc:creator> Kenan WD Stern</dc:creator><dc:creator> Carolyn Taylor</dc:creator><dc:creator> Varsha Thakur</dc:creator><dc:creator> Wayne Tworetzky</dc:creator><dc:creator> Carol Wittlieb-Weber</dc:creator><dc:creator> Kris Woldu</dc:creator><dc:creator> Mary T Donofrio</dc:creator><dc:creator> Shabnam Peyvandi</dc:creator><dc:creator> Fetal Heart Society Research Collaborative</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> Associations Between Maternal Sociodemographics and Hospital Mortality in Newborns With Prenatally Diagnosed Hypoplastic Left Heart Syndrome</dc:title><dc:identifier> pmid:37459407</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064476</dc:identifier></item><item><title> The Time to Act Is Now: Racial Disparities After Heart Transplantation</title><link/> https://pubmed.ncbi.nlm.nih.gov/37459406/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230719162154&amp;v=2.17.9.post6+86293ac<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2023 Jul 18;148(3):207-209. doi: 10.1161/CIRCULATIONAHA.123.064499. Epub 2023 Jul 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37459406/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230719162154&v=2.17.9.post6+86293ac">37459406</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064499>10.1161/CIRCULATIONAHA.123.064499</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:37459406</guid><pubDate> Mon, 17 Jul 2023 06:00:00 -0400</pubDate><dc:creator> Kiran K Khush</dc:creator><dc:creator> Hannah A Valantine</dc:creator><dc:date> 2023-07-17</dc:date><dc:source> Circulation</dc:source><dc:title> The Time to Act Is Now: Racial Disparities After Heart Transplantation</dc:title><dc:identifier> pmid:37459406</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.123.064499</dc:identifier></item></channel></rss>